Joint Formulary & PAD

Ipratropium (Nebules) - Asthma

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Nebules
Associated Icons :
Restrictions / Comments :
Important

Specialist* recommendation following patient initiation and education on nebuliser therapy, unless for administration as PSD in practice for acute attack.

* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Ipratropium (Nebules)
Indication :
Asthma
Group Name :
Nebules
Keywords :
severe acute asthma, reversible airways obstruction, bronchospasm
Brand Names Include :
Atrovent nebules
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Ipratropium (Nebules) is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Asthma.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.